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In both human and murine lupus erythematosus, high-frequency public idi-
otypic markers occur on anti-DNA antibodies (1-4), yet Igs that do not bind to
DNA can also possess the same markers (5, 6). This phenomenon, the sharing of
idiotypic specificitiesby antibodies with different antigen binding properties, was
originally described by Oudin and Cazenave (7) and is well established for
antibodies to exogenous antigens (8, 9) . It is probably due either to a V gene
rearrangement in which a gene segment related to a particular idiotype is used
for coding different Igs (10), or to a V gene mutation that affects the antigen-
binding property of an antibody but not its idiotype (11) . Antibodies with such
recurrent idiotypes, termed parallel sets (12), are thought to underlie functional
connections between B cell (orT cell) clones that respond to different antigenic
determinants (13-15).
Parallel sets of antibodies could be important in autoimmunization . When
examined in vitro, lymphocytes from patients with active lupus erythematosus
produce Igs bearing the public idiotypic marker Id-16/6, a large fraction of
which are anti-DNA antibodies . By contrast, only a small proportion of the Id-
16/6+ Igs produced by cultured lymphocytes from patients with inactive lupus
(or from normal subjects) bind to DNA (6) . However, whether the remarkable
shift in the antigen binding specificity of Id-16/6'' antibodies that occurs during
relapse of lupus erythematosus relates to functionally connected parallel sets has
not been established .
A public idiotype ofanti-DNA antibodies also exists in MRL-lpr/lprmice . This
marker, termed Id-H130, occurs in 20-40% of the serum anti-DNA antibodies
in that strain (3) . And, analogous to the findings in human lupus, cultured
lymphocytes from normal mice produce Id-H 130+ Igs that do not bind to DNA,
whereas a substantial fraction of the Id-H130+ Igs produced in vitro by MRL-
lpr/lprlymphocytes are anti-DNA antibodies (5) . Even so, ^"60% of the Id-H 130+
antibodies in MRL-lpr/lpr serum do not bind to DNA (3). To identify those
antibodies, we prepared hybridomas from MRL-lpr/lpr mice, screened them for
Id-H 130, and selected mAbs that did not bind toDNA. This report deals with a
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remarkable example of such an antibody. It binds to SmRNP antigens and is an
antiidiotype against anti-DNA and anti-gp70 antibodies. This mAb appears to
be the prototype of a population of similar antibodies in MRL-lpr/lpr serum.
Ourresultssuggest that anetworkofparallel sets ofautoantibodies, with different
autoantigen-binding properties, occurs in MRL-lpr/lpr mice.
Materials and Methods
Production ofmAbs.
￿
Spleen cells were fused with the NS-I plasmacytoma line and the
desired hybridomas were cloned by limiting dilution (16). Pooled culture fluids from the
hybridoma cell lines were affinity purified on Sepharose 4B coupled to goat anti-mouse
immunoglobulins. The bound material was eluted with 0.1 M glycine HCl (pH 2.5),
dialyzed against PBS (pH 7.4) and concentrated by ultrafiltration. The purified monoclo-
nal antibodies TEPC 183, MOPC 195, MOPC 104, UPC 10 were purchased from
Bionetics (Litton Bionetics Inc., Charleston, SC). MAb 28/12 was derived from an
unimmunized 3 month old MRL-lpr/lpr mouse; MAbs 512 and 319 are anti-DNA
antibodies derived from unimmunized (SWR X NZB)F, mice (17); mAb 514 is an IgM
anti-retroviral gp70 antibody obtained from Dr. Miles Cloyd, Duke University Medical
Center, Durham, NC (18); mAb 1417 is an IgM anti-retroviral gp70 antibody derived in
our laboratory from a NFS mouse.
Production of Monoclonal Anti-Id H130.
￿
A BALB/c mouse was hyperimmunized with
mAb H130 (2 X 106 hybridoma cells intraperitoneally biweekly three times, followed by
40 ug affinity-purified mAb H130 on days 5, 3, and 1 before fusion) and its splenocytes
were fused with NS-1 cells. Hybridomas that produced antiidiotypes against mAb H130
were selected by a direct binding assay. For this purpose, microtiter plates were coated
with either affinity-purified mAb HI 30 or TEPC 183 (0.5 ag/ml) in 0.05 M borate buffer
(pH 8.6) for 18 h at 4°C. Afterblocking with 3% BSA in PBS (1 h at room temperature),
supernatants that had been diluted 1:2 in diluting buffer (PBS, 1% BSA, 0.05% Tween)
were added to the wells and incubated for 2 h at 37°C. The plates were washed once
with 1% Tween in PBS and twice with PBS. Alkaline phosphatase-conjugated protein A
(Zymed Laboratories, San Francisco, CA) was then added and thebound enzymic activity
developedwith p-nitrophenyl-phosphate. This procedure yielded acloned hybridoma that
produced mAb 108, an IgGI antibody that bound specifically to mAb H130 in a liquid-
phase competitive assay.
Id-H130 Assay.
￿
Production and characterization of the rabbit anti-H130 reagent has
been described (19). The H130 idiotype (Id-H130) was detected by a competitive assay
(19), with the following modifications: mAb H130 (precipitated twice from culture fluid
by 50% ammonium sulphate and adjusted to a concentration of 1 mg/ml) was coupled to
biotin according to Guesdon et al. (20) and used in an enzyme-linked immunoassay.
Immulon 2 plates (Dynatech Laboratories, Inc., Alexandria, VA) were coated overnight
at 4°C with 100 Al of the rabbit anti-H130 (1 :2000) or anti-H130 (0 .5 kg/ml) mAb in
borate buffer. After blocking with 3% BSA in PBS for 1 h at room temperature, 50 Al of
the biotin labeled mAb H130 (0.2 Ag/ml) and 50 Al of the test antibody in diluting buffer
were incubated together on the plate for 1 h at 37°C. The plates were washed once with
1% Tween in PBS, twice with PBS, and then avidin-alkaline phosphatase (Boehringer
Mannheim Biochemicals, Indianapolis, IN) in diluting buffer was added. After 1 h at
37 °C, the plates were washed and the bound enzymic activity was measured.
Anti-SmRNP Activity.
￿
SmRNP was affinity purified from rabbit thymus extract on a
human anti-RNP Sepharose column . Briefly, the rabbit thymus extract was solubilized in
0.01 M phosphate, 0.35 M NaCl, 2 mM PMSF (pH 7.4) by sonication and applied to the
column. The column was rinsed with 0.01 M phosphate/0.5 M NaCl (pH 7.4); the bound
antigen was eluted with 3 M NaSCN and immediately dialyzed against PBS. The elutee,
which contains both RNP and complexed Sm antigen, was precipitated on ice with 20%
TCA for 15 min, resuspended in 20 F1 of sample buffer (0.12 M Tris-HCI, 20% glycerol,
6% SDS, 0.04 bromophenol blue, 10% 2-ME) and applied to a 10-20% acrylamide
gradient gel. To define the specificity of SmRNP binding antibodies, the polypeptides
separated by SDS-PAGE were transferred to nitrocellulose paper (21). The paper wasMIGLIORINI ET AL.
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saturated with 5% BSA in PBS for 2 h at room temperature, then individual strips were
incubated with the biotin-labeled test antibody in diluting buffer for 1 h at 22 0C. After
extensive washing with PBS-Tween 1%, the paper strips were incubated with alkaline
phosphatase-conjugated avidin (Boehringer Mannheim Biochemicals) for 2 h at 22 °C.
The immunoactive bands were visualized using 5-bromo-4-chloro-indoxyl phosphate and
nitroblue tetrazolium as the substrate (22). To measure anti-SmRNP activity, the eluate
of the anti-RNP column (5 ug/ml in borate buffer) was used to coat polystyrene plates.
After 18 h at 4'C, the plates were blocked by 3% BSA for 1 h and the antibodies or sera
were addedin diluting buffer to individual wells. The bound antibodies were detected by
alkaline phosphatase-conjugated goat anti-mouse Ig.
AntiidiotypicActivity of mAb 28/12.
￿
Polystyrene plates were coated with IgM mAbs (0 .1
tug/ml) in borate buffer, and blocked with 3% BSA in PBS. For the direct binding assay,
mAb 28/12 or control IgG antibodies were incubated in diluting buffer on the plate for
2 h at 37°C and detected by alkaline phosphatase-conjugated protein A. For the
competitive assay, the amount of mAb 28/12 that gave 50% maximum bindingto the test
mAb was preincubated with different dilutions of mAbs for 1 h at 37°C and the mixture
was transferred to the coated plates. The assay wasthen carriedon as in the direct binding
assay.
Anti-Viral Activity.
￿
Cloned polytropic retroviruses isolated in our laboratory (23) were
propagated on mink lung fibroblasts (CCL64). Supernatants from fibroblasts infected
with P1, a recombinantretrovirus, were appliedto aCon A-Sepharosecolumn (Pharmacia
Fine Chemicals, Piscataway, NY), eluted with a-methyl-D-mannoside (Sigma Chemical
Co., St. Louis, MO)and dialyzed against PBS. Afteraddition of NP40 (final concentration,
0.5%), the purified virus was applied to a Sepharose 4B-coupled anti-gp70 mAb (24).
The unbound material was removed from the column by washing with 0.5% NP40-PBS
and the gp70 was eluted with 0.1 M glycine (pH 2.5). After dialysis against PBS and
concentration, the purity of the gp70 was authenticated by SDS-PAGE. The purified
gp70 was used to coat polystyrene plates at a concentration of 1 tLg/ml. A retrovirus-
induced thymic leukemia line, provided by Dr. Hiroshi Hiai, Aichi Cancer Research
Institute, Nagoya, Japan, was used for immunofluorescent flow cytometry. Briefly, the
cells were washed twice in PBS/0.01% sodium azide; 2.5 wg of the antibody in 50 u1 of
PBS azide was added to pellets containing 106 cells. The pellets were resuspended,
incubated on ice for 30 min, washed once with cold PBS-azide, and then incubated with
50 tl of a 1/60 dilution of FITC-conjugated goat anti-mouse IgM (Meloy Laboratories
Inc., Springfield, VA). The cell pellets were washed again with PBS-azide and analyzed
by cytofluorography. Membrane lysates from this cell line were used for immune precip-
itation, as previously described (24), with minor modifications. Briefly, 2 X 107 cells were
radiolabeled with 1 mCi Na ' 211 and lactoperoxidase, washed with cold PBS, and lysed in
0.01 M Tris-HCI, 0.15 M NaCl, 0.5% NP40, and 2 mM PMSF (pH 7). The lysate was
centrifuged to remove cellular debris and precleared twice with Staph A (IgG Sorb; The
Enzyme Center, Inc., Boston, MA) coupled to rabbit anti-mouse IgM (Litton Bionetics,
Kensington, MD) and once with Staph A alone. Protein A-Sepharose 6MB beads (Phar-
macia Fine Chemicals) were coupled to rabbit anti-mouse IgM (Litton Bionetics) and
incubated 2 h at 4°C. After washing with washing buffer (PBS 0.1% BSA, 0.5% NP40, 2
mM PMSF), 10 kg of the monoclonal IgMs were incubated with 50 'U1 of the packed beads
for 2 h at 4°C. After washing, 2 X 106 cpm of the lysate were added to each tube in a
final volume of 100 jut and incubated for 18 h at 4'C. The beads were then washed five
times with 5 ml of the washing buffer and twice with PBS. The immune precipitates were
eluted by incubating in sample buffer for 3 min at 70 °C and analyzed by SDS-PAGE on
a 15% polyacrylamide gel. The dried gel was autoradiographed at -70°C with an x-ray
intensifying screen.
Results
Derivation of mAb 28/12.
￿
MRL-lpr/lpr serum contains a population of Id-
H 130' anti-DNA antibodies as well as a second Id-H 130' population that does
not bind DNA (3). To analyze the specificities of the second population, we48 6
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Analysis of the idiotype of mAb 28/12 by solid-phase competitive immunoassay.
Increasing amounts of mAb 28/12, control antibody MOPC 195, or mAb H130 were
incubated with biotin-labeled mAb H130 on plates coated with rabbit anti-H130 (A)or mouse
monoclonal anti-H130 (B). Results areexpressedas percent inhibition.
prepared mAbs by first screening MRL-lpr/lpr hybrrdomms for Id-H130, and
then for the lack ofreactivity with DNA. mAb 28/12 fulfilled these two screening
criteria. It was purified by an immunoaffinity column from the supernatant of a
clone derived by limiting dilution from the original Id-H130' 28/12 hybridoma
line. The presence of Id-H130 in the purified antibody was established with both
polyclonal and monoclonal antiidiotype reagents (Fig. 1). In liquid phase com-
petition assays with the polyclonal antiidiotype, 50% inhibition was observed with
0 .9 Ag/ml of mAb 28/12, compared with 0.09 Ag/ml of mAb H130, the
prototypic Id-H130' anti-DNA mAb (Fig. IA). With the monoclonal antiidi-
otype, the amounts required for 50% inhibition were 5 Ag/ml (mAb 28/12) and
2.2 Ag/ml (mAb H130) (Fig. I B) . In a control assay with an unrelated idi-
otype/rabbit antiidiotype system, mAb 28/12 had no inhibitory effect in amounts
up to 10 Ag/ml .
mAb 28/12 Is An Anti-SmRNP Antibody. The ligand-binding properties of
mAb 28/12 are shown in Figs. 2 and 3. The antibody did not react with single-
stranded DNA, RNA, Poly (1), or cardiolipin. However, it did bind strongly to
antigens in the SmRNP complex (Fig. 2). In an immunoblot assay, mAb 28/12
bound to a 49-kD polypeptide in the SmRNP complex; additional bands at 28,
18, 17, 13 kD, and a fainter band at 40 kD, were also observed (Fig. 3). The 28,
18, and 13 kD polypeptides are associated with the Sm antigen (25, 26). The 49-
kD polypeptide, although present in the SmRNP complex (25), is not reactive
with typical anti-Sm or anti-RNP antisera. The reaction of mAb 28/12 with
antigens of the Sm-RNP complex was confirmed by affinity chromatography of
the rabbit thymus extract with a mAb 28/12-Sepharose column . The eluate from
this column, when analyzed by SDS gel electrophoresis, contained proteins with
M, (X 10-3) of 70, 58, 49, 43, 32, 20 and 13 . These components have beenMIGLIORINI ET AL.
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FIGURE 2 .
￿
Antigen-binding properties of mAb 28/12. Increasing amounts of mAb 28/12
were incubated on plates coated with SmRNP (5 wg/ml) or single-stranded DNA (2.5 wg/ml).
The bound antibody was detected by alkaline phosphatase-conjugated goat anti-mouse Ig.
obtained by others in eluates of anti-Sm or anti-RNP Sepharose columns (25).
The 43 kD protein is not part of the complex, since it binds to normal Ig
columns. The 70 kD protein corresponds to the main antigen recognized by
anti-RNP antibodies and the 13 kD protein corresponds to the E component of
the Sm antigen. Polypeptides of MW 31-32 kD are associated with U1 RNA and
react with anti-RNP or anti-Sm antisera (25).
mAb 28/12 is an Antiidiotypic Antibody.
￿
To determine whether mAb 28/12 is
a rheumatoid factor, we tested it against a panel of other mouse mAbs (Fig. 4).
It bound to only 4 of the panel of 16 test antibodies. Those four antibodies did
not bind toa control IgG2b mAb withthe sameallotype as mAb 28/12; therefore,
they too were not rheumatoid factors. Of the four antibodies to which mAb
28/12 bound, two (mAb 512 and mAb 319) are anti-DNA mAbs derived from
(NZB X SWR)FI mice (17); the other two (mAb 514 and mAb 1417) are anti-
retroviral gp70 mAbs from (BALB/c X C57BL/6)FI (18) and NFS mice, respec-
tively.
The specificity of the binding of mAb 28/12 to mAbs 512, 319, 514, and
1417 was confirmed by liquid-phase competitive inhibition assays. Table I shows
the concentrations of various Igs that were required to cause 50% inhibition of
the binding of mAb 28/12 to the panel offour mAbs. In this checkerboard assay
system, mAbs 512 and 514 inhibited the binding of mAb 28/12 to all four test
Igs; mAb 1417 inhibited the binding ofantibody mAb 28/12 to mAbs 512, 514,
and 1417, but not to mAb 319; and mAb 319 inhibited the binding of mAb
28/12 to only mAb 1417. Four control mAbs did not inhibit any ofthe reactions
of mAb 28/12. Additional evidence for the specificity of the binding of mAb
28/12 is shown in Table II, which lists the origins and isotypes of 28 mAbs that
failed to inhibit the binding of mAb 28/12 to mAb 1417 in a liquid-phase
competitive inhibition assay.
The data presented thus far show that mAb 28/12 is both an anti-SmRNP
antibody and an antiidiotypic antibody. To pursue the latter, antigen inhibition
assays were carried out (Fig. 5). For this purpose, the two anti-DNA antibodies,
mAbs 512 and 319, were first incubated with either single-stranded DNA or
RNA and then transferred to plastic wells coated with mAb 28/12. With both488
￿
PARALLEL SETS OF AUTOANTIBODIES
FIGURE 3 .
￿
Western blot of SmRNP probed with mAb 28/12 . SmRNP polypeptides were
separated by SDS-PAGE and transferred to nitrocellulose paper . The strips were incubated
with buffer (lane 1) or biotin-labeled mAb 28/12 (]ape 2) and thebound antibody was detected
with alkaline phosphatase-conjugated avidin .
mAb 512 and mAb 319, single-stranded DNA, but not RNA, displaced the
binding reaction ; 50% inhibition of the 512-28/12 reaction occurred with 0.1
nMDNA (as phosphate), and 0.07nMDNA (as phosphate) caused 50% inhibition
of the 319-28/12 reaction . By contrast, neither gp70 nor whole retrovirus
displaced the binding of mAb 28/12 from the two anti-gp70 mAbs, mAb 514
andmAb 1417 (data not shown) .
The relationship between the anti-SmRNP activity and the antiidiotypic prop-e
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￿
Binding of mAb 28/12 to mouse IgM. mAb 28/12 (open bars) or MOPC 195
(closed bars) at a concentration of 2 kg/ml were incubated on plates coated with 0.1 ug/ml of
IgM anddetected by alkaline phosphatase-conjugated protein A.
TABLE I
Concentration ofIg Requiredfor 50% Inhibition of the Binding ofmAb 28/12
Each of the four IgMs was at a concentration of 0.1 ug/ml . The amount ofmAb 28/12 that gave
50% of the maximum binding was preincubated with different quantities of the tested Igs and
transferred to the plates . Bound mAb 28/12 was detected by alkaline phosphatase-conjugated
protein A. Results are expressed as amount (ug/ml) of the tested Ig required to achieve 50%
inhibition ofmAb 28/12 binding . 183 is TEPC183, 104E is MOPC 104E, H62/1 is a monoclonal
MRL-lpr/lpr IgMk Id-H130' anti-single-stranded DNA antibody .
* The highest concentration of 319 tested (10 ug/ml) gave 25% inhibition .
TABLE II
Isotypes and Strains ofOrigin of mAbs that Did Not Inhibit the Binding of
inAb 28/12 to mAb 1417
mAb 512 has theNZB allotype (17) and mAb 514 was derivedfrom a(C57BL/6
x BALB/c)Fj mouse.
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Solid
Liquid phase
phase
514 1417 512 319 183 104E H130 H62/1
uglml
514 0.1 2.5 0.08 >10 >10 >10 >10 >10
1417 2.0 0.2 0.02 1 .0 >10 >10 >10 >10
512 1 .3 1 .3 2.0 >10 >10 >10 >10 >10
319 6.0 >10 3.0 >10* >10 >10 >10 >10
Mouse strain Isotype Specificity
BALB/c IgM TEPC 183, MOPC 104E, H248, H152, A71
IgG UPC 10, MOPC 195, MOPC 21,J606
NZB IgM H201, H525, H528, H603
IgG H563, H567, H533, H550, H556, H549
C57BL/6 IgM H50
MRL-lpr/lpr IgM H130, H62/1
IgG H225, H241, H147, H215
A/J IgG H65
NFS IgG H1416490
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FIGURE 5.
￿
Inhibition of the binding of mAbs 512 and 319 to mAb 28/12 by DNA. Plates
were coated with 0.5 tug/ml ofmAb 28/12; the amounts of mAbs 512 or 319 required for
50% of the maximum binding to mAb 28/12 were preincubated for 1 h at 37 °C with different
amountsof single-stranded DNA or RNA and transferred to the plates. Bound antibody was
detected by alkaline phosphatase-conjugated goat anti-mouse IgM . Results are expressed as
percent inhibition . (Closed circles) mAb 319 + DNA; (open circles) mAb 319 + RNA; (closed
triangles) mAb 512 +DNA; (open triangles) mAb 512 +RNA.
pg/ml
FIGURE 6 .
￿
Inhibition of binding of mAb 28/12 to mAb 1417 by SmRNP. The eluate and
the flow through of theanti-SmRNP column (SmRNP and rabbit thymus extract depleted of
SmRNP, RTE-SmRNP) were tested for their ability to inhibit mAb 28/12 binding to mAb
1417 . mAb 28/12 was preincubated with different amounts of SmRNP or RTE-SmRNP and
transferred to plates coated with mAb 1417 . Bound mAb 28/12 was detected by alkaline
phosphatase-protein A.
erty of mAb 28/12 was investigated by a liquid-phase competitive inhibition
assay. In Fig . 6 it can be seen that the SmRNP antigen complex inhibited the
binding ofmAb 28/12 to mAb 1417 . However, significant inhibition occurred
only at a relatively high concentration of the SmRNP antigen (50% inhibition
occurred at 70 ktg/ml) . Even so, the same concentration of the rabbit thymus
extract had no inhibitory effect on the binding ofmAb 28/12 to mAb 1417 after
it was depleted ofSmRNP antigens by immunoabsorption . In another assay, theMIGLIORINI ET AL .
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FIGURE 7 .
￿
Inhibition of binding of mAb 28/12 to SmRNP by mAbs 514 and 1417 . mAb
28/12 was preincubated with different amounts of mAbs 514, 1417 or TEPC 183 (control)
and transferred to plates coated with SmRNP . BoundmAb 28/12 was detected by alkaline
phosphatase-protein A.
reverse of the preceding, both mAb 1417 and mAb 514 in the liquid-phase
completely displaced the binding ofmAb 28/12 to solid-phase SmRNP (Fig . 7) .
mAbs 512 and 319 Bind to Both DNA and Retroviral Antigens. The presence
in mAbs 512, 319, 514, and 1417 of a shared idiotypic determinant recognized
by mAb 28/12 prompted us to investigate whether these four antibodies also
share an antigen-binding property . As the two anti-gp70 mAbs, mAb 514 and
mAb 1417, did not bind to DNA, we sought evidence of gp70 binding by mAbs
319 and 512 . Cytofluorography demonstrated that both mAb 319 and mAb 512
bound to an AKR thymic leukemia line that expresses gp70 on its plasma
membrane . The component recognized by these two antibodies was further
analyzed by immunoprecipitation ofmembrane lysates from
1251 surface-labeled
cells (Fig . 8) . The standard polyclonal and monoclonal anti-retrovirus antibodies
immunoprecipitated 70 and 85 kD proteins from the cell lysates . These bands
correspond to gp70 and either an 85 kD precursor of gp70 or a detergent-
induced complex of gp70 and the retroviral protein p15 (27) . mAb 512 also
immunoprecipitated 70 and 85 kD proteins, whereas mAb 319 immunoprecipi-
tated only the 85 kD protein .
We next tested the binding of mAb 512 to affinity-purified gp70 . Purified
retrovirus obtained from a cloned viral stock was applied to a monoclonal anti-
gp70 Sepharose column (24) and the eluted 70 kD protein was used to coat
polystyrene plates for binding assays . Fig. 9 shows the ability ofmAbs 512, 514,
and 1417 to bind to the affinity-purified gp70 (mAb 319 was negative in this
assay) . Taken together, these results show that mAb 512 is directed against gp70,
whereas mAb 319 recognizes an epitope on the p85 complex that is either
contained in the p 15 moiety or in a determinant formed by the association of
p 15 and gp70 .
Antibodies Resembling mAb 28/12 in MRL-lpr/lpr Serum . MRL-lpr/lpr sera
were tested for anti-SmRNP antibodies that are also antiidiotypes against mAb
514, the standard anti-gp70 mAb. Sera containing anti-SmRNP antibodies were
pooled and passed through a pooled mouse Ig-Sepharose column to remove any492
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FIGURE 8 .
￿
SDS-PAGE analysis of cell surface proteins from an AKR thymic leukemia line .
Immunoprecipitation was performed with : goat anti-AKR gp70 (lane 1), mouse monoclonal
anti-gp70 (lane 2), MOPC104E (lane 3), mAb 512 (lane 4), mAb 319 (lane 5) .
FIGURE 9.
￿
Binding of mAbs 1417, 514, 512, 319, and MOPC 104E to gp70 . Different
amounts of the mAbs were incubatedon plates coated with 1 vg/ml of affinity-purified gp70
and detected by alkaline phosphatase-goat anti-mouse Ig . SDS-PAGE analysis of the gp70 is
shown in the inset .
rheumatoid factors . The absorbed serum was next immunoaffinity purified on a
mAb 514-Sepharose column . Antibodies in the eluate of this column bound
specifically to mAb 514 and had anti-SmRNP activity (Fig . 10) . Notably, anti-N o Y
0.8
Q 0.4
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FIGURE 10.
￿
Analysis of MRL-lpr/lpr serum. MRL-lpr/lpr serumfreedofrheumatoid factors
was passed through a mAb 514-Sepharose column. The eluate and flow-through fractions
were tested for binding to mAb 514, TEPC 183, SmRNP, and DNA.
DNA antibodies could not be detected in the eluate of the mAb-Sepharose
column . The flow-through of the mAb 514-Sepharose column also contained
anti-SmRNP activity.
Discussion
The experiments described in this paper identify a novel and theoretically
important set ofantibodies with relevance to the origin ofautoantibodies against
DNA and the SmRNP complex. The index antibody of the set, mAb 28/12,
derived from a MRL-lpr/lpr mouse, was selected for detailed analysis because it
bears a public idiotypic marker (Id-H130) of MRL-lpr/lpr anti-DNA antibodies,
but fails to bind to polynucleotide antigens. Instead, mAb 28/12 is an anti-
SmRNP antibody. It also reacts specifically with an idiotype in two anti-gp70
antibodies and in two anti-DNA antibodies. mAb 28/12, therefore, reveals an
idiotypic network consisting of anti-DNA, anti-SmRNP, and anti-gp70 antibod-
ies. Although we base this conclusion primarily on analyses of mAbs, such a
network presumably occurs in vivo because antibodies similar to mAb 28/12
were found in MRL-lpr/lpr serum.
Anti-Sm antibodies occur in only ^-25% ofhuman lupus and MRL-lpr/lpr sera
(28, 29), but they are specific for SLE (28, 30). Antibodies to single-stranded
DNA, by contrast, occur in most lupus sera but they are not specific for that
disease (31). The two kinds of autoantibodies are, therefore, considered to be
unrelated. However, Pisetsky et al. (32) recently described an MRL-lpr/lpr mAb
that binds to both single-stranded DNA and the Sm antigen, and that is idiotyp-
ically related to MRL-lpr/lpr anti-single-stranded DNA antibodies. mAb 28/12
is a notable variant of that kind ofantibody. Although it shares an idiotype with
mAb H130, a prototypic anti-DNA antibody, it is not an anti-DNA antibody but
an anti-SmRNP antibody. mAbs 28/12 and H130, therefore, represent an494
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example ofparallel sets ofautoantibodies against different autoantigens. Pisetsky
and Carter (33) found that an anti-Sm mAb and a mAb against a different
antigen in rabbit thymus extract shared the same idiotype. Recently, Kaburaki
etal.' have shown that some human anti-DNA and anti-SmRNP antibodies share
Id-16/6, a public idiotype that was originally identified in anti-DNA antibodies
(2). Thus, idiotypic links between anti-DNA and anti-SmRNP antibodies occur
in both human and murine lupus. If, as we propose, these two systems of
autoantibodies are indeed parallel sets, then they might be functionally related
(14). We may speculate that the down regulation of anti-SmRNP antibodies by
a parallel set of anti-DNA antibodies could account for the relatively low
frequency of anti-SmRNP antibodies in human and murine lupus (28, 29).
Brennan et al. (34) were able to prolong life in MRL-lpr/lpr mice by repeated
administration of an anti-Sm mAb, yet serum levels of antibodies to double-
stranded DNA were unaffected. However, antibodies to single-stranded DNA
were not measured in their experiments.
The fine specificity of mAb 28/12 as an anti-SmRNP antibody differs some-
what from the binding properties of previously described anti-SmRNP antibod-
ies. When used asan immunoabsorbent, mAb 28/12 removes from rabbit thymus
extract a group of polypeptides, most of which have molecular masses identical
to antigens of the SmRNP complex. In immunoblots, mAb 28/12 reacted with
49, 28, 18, 17, and 13 kD polypeptides. Anti-Sm mAbs can react with multiple
low molecular mass polypeptides (35, 36), which could be either degradation
products of higher molecular mass structures or distinct molecules that share
one or more epitopes. However, no previously described anti-Sm or anti-RNP
mAb reacts with a 49 kD polypeptide, as shown here with mAb 28/12.
Another interesting property ofmAb 28/12 is its behaviour as an antiidiotypic
antibody. The binding of mAb 28/12 to other Igs cannot be explained by
rheumatoid factor or anti-allotypic activity. Of a total of 32 mAbs tested in
various systems (Tables I and II), mAb 28/12 bound to only 4. Moreover, its
bindingto two anti-DNA antibodies (mAbs 512 and 319) was displaced by DNA,
whereas a similarly charged nucleic acid, RNA, had no such effect. The antigen-
specific displacement ofmAb 28/12 from mAbs 512 and 319 indicates that their
antigen-binding sites contain the idiotope recognized by mAb 28/12. The
idiotope in the two anti-gp70 antibodies, mAbs 514 and 1417, may reside in
their framework regions, since neither gp70 nor intact retrovirus inhibited their
binding to mAb 28/12. We do not yet know whether the idiotope shared by
these four mAbs is Ig chain-specific, or whether it is an antigenic surface formed
by both the H and L chains. Nevertheless, it is interesting to consider that the
framework region of one antibody could share an idiotope with the antigen-
binding region of another antibody. Idiotope sharing by different Ig domains
has been found in the variable and constant regions of rheumatoid factors (37)
and is due to a recurrent tripeptide sequence in the two regions ofthe molecule
(38).
A striking aspect of the four mAbs that mAb 28/12 recognizes is that all of
them are anti-retrovirus antibodies. mAbs 514 and 1417 have been shown
' Kaburaki,J., andB. D. Stollar. Identification of human anti-DNA, anti-RNP andanti-Sm serum
antibodies bearingthe crossreactive 16/6 idiotype. Analysis ofsera fromJapanese patients. Submitted
for publication.MIGLIORINI ET AL.
￿
495
previously (18) to bind specifically to the gp70 of recombinant leukemogenic
viruses. mAb 512 was shown here to bind to the gp70 of a cloned leukemogenic
retrovirus and mAb 319 binds to either the gp70-p15 complex of the retroviral
envelope or to p 15 itself. These results are ofeven further interest because mAbs
512 and 319 are also typical anti-single-stranded DNA autoantibodies that react
with poly(I) and Z-DNA (mAb 319), and poly(dT) and poly(I) (mAb 512) (17).
Their ability to bind gp70 was investigated only after we found that mAb 28/12
is an antiidiotype against two known anti-gp70 antibodies, mAbs 514 and 1417 .
Thus, gp70 will have to be added to the list of antigens with which anti-DNA
autoantibodies can crossreact, a list that includes cytoskeleton proteins (39), the
Fc portion of IgG (40, 41), cell membrane proteins (42, 43), phospholipids (44),
and bacterial polysaccharides (45) .
mAb 28/12, as well as the anti-(anti-gp70) antibodies with anti-SmRNP activity
we found in MRL-lpr/lpr serum, has the general properties predicted by Plotz
(46); i. e., anti-(anti-viral) antibodies with autoantibody activity. Bunn et al. (47)
have discussed the possibility that autoantibodies of the PL-12 type, which react
with a cellular protein as well as certain tRNAs, are antiidiotypes of anti-viral
antibodies. Plotz's idea implies that pathogenetic autoantibodies can originate
from perturbations of networks of antibodies against exogenous antigens. In
principle, our results support his hypothesis. However, the anti-gp70 antibodies
in the system we studied are probably not induced by exogenous infectious
particles. On the contrary, they are more likely to represent autoantibodies
against the endogenous gp70 that is produced from early life in MRL-lpr/lpr
mice (48, 49) .
Our results suggest that the anti-gp70, anti-DNA, and anti-SmRNP antibodies
of MRL-lpr/lpr mice constitute a network of idiotypically related autoantibodies.
The autoantibodies in this network seem to have a high degree of complemen-
tarity, or mimicry. Antiidiotypes against an IgG anti-DNA mAb have been found
in the serum of (NZB X NZW)F, mice by Eilat et al . (50), who also isolated two
monoclonal examples of such antiidiotypes. Lymberi et al. (51) and Monestier et
al. (52) have found extensive idiotypic relatedness among the natural autoanti-
bodies produced by normal mice. Many of those antibodies bind to DNA (53).
Mutual V region-dependent reactivity also occurs in high frequency among IgM
mAbs derived from neonatal mice (54). These aboriginal antibodies of the
preimmune repertoire thus resemble, in both their idiotypic organization and
ligand-binding properties, the autoantibodies of lupus. It seems plausible, there-
fore, that the autoantibodies of this disease arise by expansion of a pool of
idiotypically related, germline-encoded antibodies with anti-self reactivity . Our
data suggest the hypothesis that some anti-SmRNP antibodies arise by mutation
of a V gene segment that encodes anti-DNA antibodies. Such a process could
account for the sharing of idiotypes by anti-SmRNP and anti-DNA antibodies
(shown here), the ability of a mAb to bind to both SmRNP and DNA (32), as
well as the random occurrence of anti-SmRNP antibodies in MRL-lpr/lpr mice,
all of which produce anti-DNA antibodies (28). Structural studies of such au-
toantibody pairs, now in progress, should reveal the basis of their observed
serological relationship.496
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Summary
The public idiotype Id-H130 occurs in MRL-lpr/lpr serum both on a high
proportion ofanti-DNA autoantibodies as well as on antibodies that do not bind
to DNA. To define members of the latter population, we prepared hybridomas
and selected Id-H130' mAbs that did not bind to DNA. One such antibody,
mAb 28/12, was found to be an anti-SmRNP antibody. To determine whether
mAb 28/12 had rheumatoid factor activity, we tested its ability to bind, in a
solid-phase assay, to 16 mouse IgM mAbs. mAb 28/12 bound to only four ofthe
panel, two anti-DNA antibodies (mAbs 512 and 319) and two anti-gp70 antibod-
ies (mAbs 514 and 1417). In a liquid-phase competition assay with a panel of 32
monoclonal IgM and IgG antibodies, includingallotype-matched Igs, mAb 28/12
reacted only with mAbs 512, 319, 514, and 1417. The binding of mAb 28/12
to mAbs 512 and 319 was displaced by DNA, but not by RNA, indicating that
the idiotype it defines (Id-28/12) is in the antigen-binding region o£the two anti-
DNA antibodies. In the two anti-gp70 antibodies (mAbs 514 and 1417), Id-
28/12 seems to occur in the framework region. To determine if all four Id-
28/12+ antibodies shared a common antigen-binding property, they were tested
for their ability to react with DNA and gp70. The two anti-gp70 antibodies did
not bind to DNA. However, the two anti-DNA antibodies were found to
immunoprecipitate viralproteins from retrovras-infected cells. mAb 512reacted
with gp70, both in cell membrane lysates and in purified form; mAb 319 reacted
with gp85, which contains both gp70 and the retroviral protein p15. Antibodies
with properties similar to those ofmAb 28/12 were found in MRL-lpr/lpr serum.
It was possible, by affinity chromatography on an anti-gp70 antibody column, to
isolate from serum those anti-(anti-gp70) antibodies with anti-SmRNP activity.
These results show that parallel sets of autoantibodies, which share a common
idiotype, but which bind to different autoantigens, occur in MRL-lpr/lpr mice.
Some populations of anti-DNA, anti-SmRNP, and anti-gp70 antibodies appear
to constitute a network of autoantibodies in that strain. We speculate that part
of the anti-SmRNP population of autoantibodies can arise by mutation of
germline-encoded anti-DNA antibodies.
We thankJames Cataldo and Ken Bauer for their excellent technical assistance.
Receivedfor publication 18 September 1986.
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